Company profile

Signos

Metabolic Health & NutritionSeries B stage

Company profile

About Signos

Signos is a real-time metabolic health platform that combines an AI-powered app with a continuous glucose monitor to help with weight management.

Company description Signos official website

Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Signos?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • glucose dysregulation
  • metabolic health
  • obesity
  • weight management

Who it serves

  • employers
  • health partners
  • health plans
  • individual consumers age 18+

Deployment & integration

Cloud Saas · Embedded deployment with recorded integration context.

Recorded integration context: Apple Health, Dexcom Stelo CGM, Google Health Connect, smart scales, smartwatches.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

First and only FDA-cleared AI-driven app and CGM for weight management and wellness. Partnership with Berry Street for dietitian services where 95% of members pay $0.

Partnerships

Recorded partners

  • Berry Street (registered dietitian services)
  • Dexcom (Stelo CGM sensor provider)
  • OpenLoop Health (clinical services provider)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Signos Glucose Monitoring System

AI-powered CGM platform for weight management and metabolic health

Platform · Cloud SaaSCompany source

Stelo Glucose Biosensor

15-day continuous glucose biosensor integrated with Signos platform

Device · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

86% of members report success in their 1st month

Weight management and metabolic health outcomes

87% of CGM users change food choices

Based on glucose feedback

Nearly 50% more likely to move when seeing glucose spike

Behavioral change from real-time feedback

Over 90% say CGMs help lead healthier lifestyle

User-reported lifestyle improvement

Darren

Learning to hack metabolism and understand body better for weight management

Getting a ton of compliments with very obvious impact

Kay C.

Weight loss after trying diets and exercise without success

Successfully lost weight - described as the only thing that helped after trying everything

Kim, 51

Weight loss during hormonal changes when old strategies stopped working

Steady weight loss achieved by adjusting habits with confidence using real glucose data

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Signos

Recent articles published on Signos's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Metabolic Health & Nutrition

Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon